TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial Comparing the Effects on Psychosocial Functioning of Cognitive Rehabilitation Versus Psychoeducation in Borderline Personality Disorder
Brief Summary: Study design was a multicenter, randomized, rater-blind clinical trial. There were two-parallel arms (1:1) to evaluate functional, clinical and cognitive efficacy of a specific cognitive rehabilitation group intervention (CR) compared with a psychoeducational group intervention (PE) in subjects with Borderline Personality Disorder (BPD).


Options:
A: Arm Label: active anodal tDCS to ventrolateral prefrontal cortex (VLPFC); Type: ACTIVE_COMPARATOR; Interventions: Device: Transcranial direct current stimulation | Arm Label: sham anodal tDCS to VLPFC; Type: SHAM_COMPARATOR; Interventions: Device: Transcranial direct current stimulation | Arm Label: Discontinued prior to randomization; Type: OTHER; Interventions: Other: No intervention | Intervention Type: DEVICE; Name: Transcranial direct current stimulation; Assigned to Arm(s): active anodal tDCS to ventrolateral prefrontal cortex (VLPFC), sham anodal tDCS to VLPFC | Intervention Type: OTHER; Name: No intervention; Assigned to Arm(s): Discontinued prior to randomization
B: Arm Label: cognitive remediation; Type: EXPERIMENTAL; Interventions: Other: cognitive remediation | Arm Label: Psychoeducation; Type: ACTIVE_COMPARATOR; Interventions: Other: Psychoeducation | Intervention Type: OTHER; Name: cognitive remediation; Assigned to Arm(s): cognitive remediation | Intervention Type: OTHER; Name: Psychoeducation; Assigned to Arm(s): Psychoeducation
C: Arm Label: Brexpiprazole 2-3 Milligrams Per Day; Type: EXPERIMENTAL; Interventions: Drug: Brexpiprazole | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Brexpiprazole; Assigned to Arm(s): Brexpiprazole 2-3 Milligrams Per Day | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Mindfulness skills; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness skills training | Arm Label: Interpersonal effectiveness skills; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Interpersonal Effectiveness skills training | Intervention Type: BEHAVIORAL; Name: Mindfulness skills training; Assigned to Arm(s): Mindfulness skills | Intervention Type: BEHAVIORAL; Name: Interpersonal Effectiveness skills training; Assigned to Arm(s): Interpersonal effectiveness skills

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial Comparing the Effects on Psychosocial Functioning of Cognitive Rehabilitation Versus Psychoeducation in Borderline Personality Disorder
Brief Summary: Study design was a multicenter, randomized, rater-blind clinical trial. There were two-parallel arms (1:1) to evaluate functional, clinical and cognitive efficacy of a specific cognitive rehabilitation group intervention (CR) compared with a psychoeducational group intervention (PE) in subjects with Borderline Personality Disorder (BPD).


Options:
A: Arm Label: cognitive remediation; Type: EXPERIMENTAL; Interventions: Other: cognitive remediation | Arm Label: Psychoeducation; Type: ACTIVE_COMPARATOR; Interventions: Other: Psychoeducation | Intervention Type: OTHER; Name: cognitive remediation; Assigned to Arm(s): cognitive remediation | Intervention Type: OTHER; Name: Psychoeducation; Assigned to Arm(s): Psychoeducation
B: Arm Label: Case management; Type: EXPERIMENTAL; Interventions: Behavioral: Case management | Arm Label: Enhanced usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Enhanced usual care | Intervention Type: BEHAVIORAL; Name: Case management; Assigned to Arm(s): Case management | Intervention Type: OTHER; Name: Enhanced usual care; Assigned to Arm(s): Enhanced usual care
C: Arm Label: Brief Admission; Type: EXPERIMENTAL; Interventions: Other: Brief Admission | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Brief Admission; Assigned to Arm(s): Brief Admission
D: Arm Label: Short-term MBT; Type: EXPERIMENTAL; Interventions: Other: Short-term MBT | Arm Label: Long-term MBT; Type: ACTIVE_COMPARATOR; Interventions: Other: Long-term MBT | Intervention Type: OTHER; Name: Short-term MBT; Assigned to Arm(s): Short-term MBT | Intervention Type: OTHER; Name: Long-term MBT; Assigned to Arm(s): Long-term MBT

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial Comparing the Effects on Psychosocial Functioning of Cognitive Rehabilitation Versus Psychoeducation in Borderline Personality Disorder
Brief Summary: Study design was a multicenter, randomized, rater-blind clinical trial. There were two-parallel arms (1:1) to evaluate functional, clinical and cognitive efficacy of a specific cognitive rehabilitation group intervention (CR) compared with a psychoeducational group intervention (PE) in subjects with Borderline Personality Disorder (BPD).


Options:
A: Arm Label: Dynamic Cognitive Intervention Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Dynamic Cognitive Intervention Group | Arm Label: No Additional Intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dynamic Cognitive Intervention Group; Assigned to Arm(s): Dynamic Cognitive Intervention Group
B: Arm Label: General Psychiatric Management (GPM; Gunderson & Links, 2008); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Psychiatric Management | Arm Label: GPM plus Motive-Oriented Therapeutic Relationship; Type: EXPERIMENTAL; Interventions: Behavioral: Psychiatric Management, Behavioral: Motive-oriented therapeutic relationship/Plan Analysis | Intervention Type: BEHAVIORAL; Name: Psychiatric Management; Assigned to Arm(s): GPM plus Motive-Oriented Therapeutic Relationship, General Psychiatric Management (GPM; Gunderson & Links, 2008) | Intervention Type: BEHAVIORAL; Name: Motive-oriented therapeutic relationship/Plan Analysis; Assigned to Arm(s): GPM plus Motive-Oriented Therapeutic Relationship
C: Arm Label: cognitive remediation; Type: EXPERIMENTAL; Interventions: Other: cognitive remediation | Arm Label: Psychoeducation; Type: ACTIVE_COMPARATOR; Interventions: Other: Psychoeducation | Intervention Type: OTHER; Name: cognitive remediation; Assigned to Arm(s): cognitive remediation | Intervention Type: OTHER; Name: Psychoeducation; Assigned to Arm(s): Psychoeducation
D: Arm Label: App-Condition; Type: EXPERIMENTAL; Interventions: Device: Monsenso DBT-app and IT monitoring program | Arm Label: Paperdiary-condition; Type: ACTIVE_COMPARATOR; Interventions: Other: Paper diary sheet | Intervention Type: OTHER; Name: Paper diary sheet; Assigned to Arm(s): Paperdiary-condition | Intervention Type: DEVICE; Name: Monsenso DBT-app and IT monitoring program; Assigned to Arm(s): App-Condition

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial Comparing the Effects on Psychosocial Functioning of Cognitive Rehabilitation Versus Psychoeducation in Borderline Personality Disorder
Brief Summary: Study design was a multicenter, randomized, rater-blind clinical trial. There were two-parallel arms (1:1) to evaluate functional, clinical and cognitive efficacy of a specific cognitive rehabilitation group intervention (CR) compared with a psychoeducational group intervention (PE) in subjects with Borderline Personality Disorder (BPD).


Options:
A: Arm Label: meditation; Type: EXPERIMENTAL; Interventions: Behavioral: Central Meditation and Imagery Therapy | Arm Label: wait list; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Central Meditation and Imagery Therapy; Assigned to Arm(s): meditation
B: Arm Label: cognitive remediation; Type: EXPERIMENTAL; Interventions: Other: cognitive remediation | Arm Label: Psychoeducation; Type: ACTIVE_COMPARATOR; Interventions: Other: Psychoeducation | Intervention Type: OTHER; Name: cognitive remediation; Assigned to Arm(s): cognitive remediation | Intervention Type: OTHER; Name: Psychoeducation; Assigned to Arm(s): Psychoeducation
C: Arm Label: No text messages; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Supportive and interactive text messages; Type: EXPERIMENTAL; Interventions: Other: Supportive and interactive text messages | Intervention Type: OTHER; Name: Supportive and interactive text messages; Assigned to Arm(s): Supportive and interactive text messages
D: Intervention Type: DRUG; Name: Olanzapine; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Aerobic Training on Bronchial Hyperresponsiveness and Systemic Inflammation in Patients With Moderate or Severe Asthma: a Randomized Controlled Trial
Brief Summary: Exercise training has been proposed as adjunctive therapy in asthma to improve many clinical outcomes; however its effects on bronchial hyperresponsiveness (BHR) and inflammation, characteristic features in asthma, remains poorly understood. We aim to investigate the effects of aerobic training on BHR (primary aim) and systemic inflammation (secondary aim). In addition, clinical control and health related quality of life (HRQoL) will be also assessed.


Options:
A: Arm Label: Patient cousenling; Type: OTHER; Interventions: Other: Aerobic training | Intervention Type: OTHER; Name: Aerobic training; Assigned to Arm(s): Patient cousenling
B: Arm Label: Aerobic exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Aerobic exercise | Arm Label: Usual care; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: Aerobic exercise; Assigned to Arm(s): Aerobic exercise | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual care
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Lifestyle intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Lifestyle intervention
D: Arm Label: Aerobic training; Type: ACTIVE_COMPARATOR; Interventions: Other: Aerobic training, Other: Breathing exercise | Arm Label: Breathing exercise; Type: SHAM_COMPARATOR; Interventions: Other: Breathing exercise | Intervention Type: OTHER; Name: Aerobic training; Assigned to Arm(s): Aerobic training | Intervention Type: OTHER; Name: Breathing exercise; Assigned to Arm(s): Aerobic training, Breathing exercise

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase 4 Study of the Impact of Daily Bathing With Chlorhexidine-gluconate Impregnated Bathing Cloths on Nosocomial Infections in Critically Ill Patients
Brief Summary: Healthcare-associated infections are a major cause of morbidity among critically ill patients. Bathing critically ill patients with cloths impregnated with the broad-spectrum antimicrobial agent chlorhexidine-gluconate may decrease healthcare-associated infections. The purpose of this study is to evaluate the effect of daily bathing with disposable chlorhexidine-impregnated bathing cloths, as compared to daily bathing with disposable standard non-chlorhexidine-impregnated bathing cloths, on the rates of healthcare-associated infections in critically-ill patients.

Hypothesis: Daily bathing of the skin with chlorhexidine-impregnated bathing cloths will result in reduced rates of healthcare-associated infections in patients admitted to intensive care units (ICU).


Options:
A: Arm Label: Chlorhexidine bathing; Type: EXPERIMENTAL; Interventions: Other: Chlorhexidine bathing | Arm Label: Non-chlorhexidine bathing; Type: ACTIVE_COMPARATOR; Interventions: Other: Non-chlorhexidine bathing | Intervention Type: OTHER; Name: Chlorhexidine bathing; Assigned to Arm(s): Chlorhexidine bathing | Intervention Type: OTHER; Name: Non-chlorhexidine bathing; Assigned to Arm(s): Non-chlorhexidine bathing
B: Arm Label: Chromogenic Arm; Type: ACTIVE_COMPARATOR; Interventions: Other: Chromogenic surveillance | Arm Label: Molecular Arm; Type: ACTIVE_COMPARATOR; Interventions: Other: Molecular surveillance | Intervention Type: OTHER; Name: Chromogenic surveillance; Assigned to Arm(s): Chromogenic Arm | Intervention Type: OTHER; Name: Molecular surveillance; Assigned to Arm(s): Molecular Arm
C: Arm Label: Soap bathing; Type: PLACEBO_COMPARATOR; Interventions: Drug: Soap | Arm Label: 2% chlorhexidine wipes; Type: EXPERIMENTAL; Interventions: Drug: 2% chlorhexidine wipe | Intervention Type: DRUG; Name: 2% chlorhexidine wipe; Assigned to Arm(s): 2% chlorhexidine wipes | Intervention Type: DRUG; Name: Soap; Assigned to Arm(s): Soap bathing
D: Arm Label: Intervention Arm; Type: EXPERIMENTAL; Interventions: Drug: 4% chlorhexidine gluconate soap-like solution | Arm Label: Control Arm; Type: ACTIVE_COMPARATOR; Interventions: Other: standard soap | Intervention Type: DRUG; Name: 4% chlorhexidine gluconate soap-like solution; Assigned to Arm(s): Intervention Arm | Intervention Type: OTHER; Name: standard soap; Assigned to Arm(s): Control Arm

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A High Protein Weight Loss Intervention for Sarcopenic Obesity in Women
Brief Summary: The purpose of the trial is to assess the effects of combining regular, generous intakes of high quality protein (primarily from lean pork and other animal source proteins) with calorie restriction on functional status and lean muscle mass in frail, obese, women who participate in a 6 month intervention and 9 month intervention.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ADA 2003 | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Low Glycemic index (LGI) diet | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: MUFA diet | Intervention Type: BEHAVIORAL; Name: MUFA diet; Assigned to Arm(s): 3 | Intervention Type: BEHAVIORAL; Name: ADA 2003; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Low Glycemic index (LGI) diet; Assigned to Arm(s): 2
B: Arm Label: Weight loss high protein; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Protein supplementation, Behavioral: Diet counseling and group education lessons | Arm Label: Weight loss control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Diet counseling and group education lessons | Intervention Type: DIETARY_SUPPLEMENT; Name: Protein supplementation; Assigned to Arm(s): Weight loss high protein | Intervention Type: BEHAVIORAL; Name: Diet counseling and group education lessons; Assigned to Arm(s): Weight loss control, Weight loss high protein
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: low carbohydrate diet | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: low fat diet | Intervention Type: BEHAVIORAL; Name: low carbohydrate diet; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: low fat diet; Assigned to Arm(s): 2
D: Arm Label: Low-carbohydrate diet; Type: EXPERIMENTAL; Interventions: Behavioral: low-carbohydrate diet | Arm Label: Low-fat diet; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: low-fat diet | Intervention Type: BEHAVIORAL; Name: low-carbohydrate diet; Assigned to Arm(s): Low-carbohydrate diet | Intervention Type: BEHAVIORAL; Name: low-fat diet; Assigned to Arm(s): Low-fat diet

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Expanding Paramedicine in the Community (Study)
Brief Summary: Initiatives aimed at reducing Emergency Department (ED) wait times and improved community health initiatives are major priorities in Canada. Three of the most common chronic diseases worldwide are Diabetes Mellitus (DM), Congestive Heart Failure (CHF) and Chronic Obstructive Pulmonary Disease (COPD). These diseases are on the rise and currently cost the Canadian health care system billions of dollars every year including the cost of hospitalizations and ED visits. The existing health care system does not have the resources and manpower to effectively care for these patients in the future.

Paramedics are currently employed to provide Emergency Medical Services in remote, rural and urban settings in Canada.

They are highly trained health care practitioners that are mobile in the community and currently work in a physician medically delegated act model and therefore are positioned to take on new collaborative roles to deliver patient care in the community setting. Increased community paramedic care could decrease the utilization of the health care system resources for patients with chronic disease. Using a randomized control trial design we will attempt to answer the question of whether whether non-emergency community paramedics conducting home visits to undertake assessments and evidence-based treatments of patients in partnership with family doctors will decrease the rate of patient hospitalization.


Options:
A: Arm Label: QualiCCare education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: active comparator, QualiCCare education | Arm Label: usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: active comparator, QualiCCare education; Assigned to Arm(s): QualiCCare education
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention | Intervention Type: BEHAVIORAL; Name: Intervention; Assigned to Arm(s): Intervention
C: Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Arm Label: Community Paramedicine; Type: EXPERIMENTAL; Interventions: Other: Community Paramedicine | Intervention Type: OTHER; Name: Community Paramedicine; Assigned to Arm(s): Community Paramedicine | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care
D: Arm Label: NMS; Type: EXPERIMENTAL; Interventions: Other: New Medicine Service | Arm Label: Current Practice; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: New Medicine Service; Assigned to Arm(s): NMS

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Expanding Paramedicine in the Community (Study)
Brief Summary: Initiatives aimed at reducing Emergency Department (ED) wait times and improved community health initiatives are major priorities in Canada. Three of the most common chronic diseases worldwide are Diabetes Mellitus (DM), Congestive Heart Failure (CHF) and Chronic Obstructive Pulmonary Disease (COPD). These diseases are on the rise and currently cost the Canadian health care system billions of dollars every year including the cost of hospitalizations and ED visits. The existing health care system does not have the resources and manpower to effectively care for these patients in the future.

Paramedics are currently employed to provide Emergency Medical Services in remote, rural and urban settings in Canada.

They are highly trained health care practitioners that are mobile in the community and currently work in a physician medically delegated act model and therefore are positioned to take on new collaborative roles to deliver patient care in the community setting. Increased community paramedic care could decrease the utilization of the health care system resources for patients with chronic disease. Using a randomized control trial design we will attempt to answer the question of whether whether non-emergency community paramedics conducting home visits to undertake assessments and evidence-based treatments of patients in partnership with family doctors will decrease the rate of patient hospitalization.


Options:
A: Arm Label: COPD Web; Type: EXPERIMENTAL; Interventions: Behavioral: COPD Web | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: COPD Web; Assigned to Arm(s): COPD Web
B: Arm Label: Pulmonary Rehabilitation Group; Type: EXPERIMENTAL; Interventions: Behavioral: Pulmonary Intervention | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Pulmonary Intervention; Assigned to Arm(s): Pulmonary Rehabilitation Group
C: Arm Label: Telemedicine; Type: ACTIVE_COMPARATOR; Interventions: Device: Telemedicine | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Telemedicine; Assigned to Arm(s): Telemedicine
D: Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Arm Label: Community Paramedicine; Type: EXPERIMENTAL; Interventions: Other: Community Paramedicine | Intervention Type: OTHER; Name: Community Paramedicine; Assigned to Arm(s): Community Paramedicine | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Brief Summary: The primary objective of this study is to evaluate the rate of stroke and/or death in patients treated with the Wingspan Stent System, according to the Indications for Use, within 72 hours post procedure.


Options:
A: Arm Label: Intracranial stenting group; Type: EXPERIMENTAL; Interventions: Procedure: Intracranial stenting group | Arm Label: medical group; Type: ACTIVE_COMPARATOR; Interventions: Drug: medical group | Intervention Type: PROCEDURE; Name: Intracranial stenting group; Assigned to Arm(s): Intracranial stenting group | Intervention Type: DRUG; Name: medical group; Assigned to Arm(s): medical group
B: Arm Label: Wingspan Stent System; Type: OTHER; Interventions: Device: Wingspan Stent System | Intervention Type: DEVICE; Name: Wingspan Stent System; Assigned to Arm(s): Wingspan Stent System
C: Arm Label: Stent Group; Type: EXPERIMENTAL; Interventions: Device: Pharos Vitesse Neurovascular Stent System (Stent implantation) + Medical therapy (Aspirin and Clopidogrel) | Arm Label: Medical Therapy Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aspirin and Clopidogrel (Medical therapy) | Intervention Type: DEVICE; Name: Pharos Vitesse Neurovascular Stent System (Stent implantation) + Medical therapy (Aspirin and Clopidogrel); Assigned to Arm(s): Stent Group | Intervention Type: DRUG; Name: Aspirin and Clopidogrel (Medical therapy); Assigned to Arm(s): Medical Therapy Group
D: Arm Label: Antiplatelet; Type: ACTIVE_COMPARATOR; Interventions: Drug: aspirin, Drug: clopidogrel, Other: placebo | Arm Label: Blood pressure; Type: ACTIVE_COMPARATOR; Interventions: Other: Target of Blood Pressure | Intervention Type: DRUG; Name: aspirin; Assigned to Arm(s): Antiplatelet | Intervention Type: DRUG; Name: clopidogrel; Assigned to Arm(s): Antiplatelet | Intervention Type: OTHER; Name: Target of Blood Pressure; Assigned to Arm(s): Blood pressure | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): Antiplatelet

Answer: B